首页> 外国专利> 4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-BENZONITRILE HYDROCHLORIDE IN CRYSTALLINE FORM CHARACTERIZED BY AN X-RAY DIAGRAM, A PROCESS FOR THE PREPARATION THEREOF AND A PHARMACEUTICAL PREPARATION COMPRISING SAID CRYSTALLINE HEMIHYDRATE FORM

4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-BENZONITRILE HYDROCHLORIDE IN CRYSTALLINE FORM CHARACTERIZED BY AN X-RAY DIAGRAM, A PROCESS FOR THE PREPARATION THEREOF AND A PHARMACEUTICAL PREPARATION COMPRISING SAID CRYSTALLINE HEMIHYDRATE FORM

机译:X射线图表征的结晶形式的4-(5,6,7,8-四氢咪唑并(1,5-A)吡啶基-5-基)-苯甲酰氯,其制备方法和药物制备方法所说的结晶水合物形式

摘要

The present invention relates to a crystalline form of 4- (5,6,7,8-tetrahydroimidazo [1,5-a] pyridin-5-yl) -benzonitrile hydrochloride of formula (Ia) containing crystal water and its It relates to a manufacturing method. The crystalline form shows excellent storage stability.
机译:本发明涉及含有结晶水的式(Ia)的4-(5,6,7,8-四氢咪唑并[1,5-a]吡啶-5-基)-苄腈盐酸盐的结晶形式,并且涉及一种制造方法。结晶形式显示出极好的储存稳定性。

著录项

  • 公开/公告号KR100191360B1

    专利类型

  • 公开/公告日1999-06-15

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG.;

    申请/专利号KR19910000244

  • 发明设计人 유타 이브라힘;

    申请日1991-01-10

  • 分类号C07D471/04;

  • 国家 KR

  • 入库时间 2022-08-22 02:16:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号